BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

BGF World Gold A2 vs UBS Lux Equity Fund Biotech USD

1. BGF World Gold A2

  • Security

    BGF World Gold A2 USD

  • Fee

    2.48%

  • ISIN

    LU0055631609

  • Holdings

    8

2. UBS Lux Equity Fund Biotech USD

  • Security

    UBS Lux Equity Fund Biotech USD P-acc

  • Fee

    2.25%

  • ISIN

    LU0069152568

  • Holdings

    10

Fund Holdings

We have information about 12 holdings in BGF World Gold A2, where the largest holding is Agnico Eagle Mines (7.29), followed by Kinross Gold (7.09) and Endeavour Mining (6.15). In comparison with UBS Lux Equity Fund Biotech USD, we have 14 holdings where Regeneron Pharmaceuticals is the largest holding (10.04), followed by Vertex (9.35) and Moderna (9.21).

All Holdings

Here we compare the holdings in BGF World Gold A2 and UBS Lux Equity Fund Biotech USD.

BGF World Gold A2 UBS Lux Equity Fund Biotech USD
1. Agnico Eagle Mines Ltd
Canada
7.29 %
1. Regeneron Pharmaceuticals Inc
10.04 %
2. Kinross Gold Corp
Canada
7.09 %
2. Vertex Pharmaceuticals Inc
9.35 %
3. Endeavour Mining Plc
UK
6.15 %
3. Moderna Inc
9.21 %
4. Newmont Corp
USA
5.61 %
4. Alnylam Pharmaceuticals Inc
6.96 %
5. Northern Star Resources Ltd
Australia
5.18 %
5. AbbVie Inc
USA
5.53 %
6. Wheaton Precious Metals Corp
Canada
4.89 %
6. Gilead Sciences Inc
USA
4.66 %
7. Lundin Gold Inc
Canada
4.01 %
7. Amgen Inc
4.3 %
8. Alamos Gold Inc
Canada
3.86 %
8. BioNTech SE
4.13 %
- 9. Karuna Therapeutics Inc
3.75 %
- 10. Royalty Pharma Plc
3.37 %

The list of fund holdings was last updated on June 5, 2025.